Trademark Overview
On Friday, February 6, 2026, a trademark application was filed for MEDIVIVE with the United States Patent and Trademark Office. The USPTO has given the MEDIVIVE trademark a serial number of 99638938. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, June 17, 2026. This trademark is owned by Helivore Holdings Ltd.. The MEDIVIVE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Providing temporary use of non-downloadable cloud-based software for healthcare professionals to order medical supplies, manage patient prescriptions, and process secure uploads of prescription documents; Software as a service (SAAS) services featuring software for physicians to place orders for injectable pharmaceuticals, upload and store electronic prescriptions, and track inventory of medical goods
Pharmaceutical preparations for regenerative and anti-aging purposes; Pharmaceutical preparations for medical use in cellular energy support, anti-aging therapy, and metabolic enhancement; pharmaceutical preparations containing nicotinamide adenine dinucleotide (NAD+) for use in anti-aging and metabolic-enhancement therapies; injectable pharmaceutical formulations containing nicotinamide adenine dinucleotide (NAD+) for medical use in cellular energy support, anti-aging therapy, and metabolic enhancement; auto-injector pens sold pre-filled with pharmaceutical preparations containing NAD+ for subcutaneous or intramuscular administration
